Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon Read more
Lilly and Aduro Biotech Announce Research Collaboration and License Agreement to Develop Novel Immunotherapies Read more
Novartis announces offer to acquire CellforCure to expand manufacturing capacity for innovative cell and gene therapies Read more
Astellas & Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI (enzalutamide) in Men with mHSPC Read more